Related Experiment Video
Updated: Mar 12, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Non-Tuberculous Mycobacteria: Classification, Diagnostics, and Therapy
I Porvaznik1,2, I Solovič3, J Mokrý4
1Department of Pulmonary Diseases and Thoracic Surgery, National Institute for Tuberculosis, 1 Vysne Hagy, 05984, Vysoké Tatry, Slovakia. porvaznik@hagy.sk.
Non-tuberculous mycobacteria (NTM) cause lung infections, with increasing incidence globally. Differentiating NTM disease from other respiratory conditions, like tuberculosis sequelae, is crucial for effective, individualized treatment.
Area of Science:
- Microbiology
- Pulmonology
- Infectious Diseases
Background:
- Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms, distinct from Mycobacterium tuberculosis.
- Over 140 NTM species are identified, commonly causing pulmonary infections (65-90%).
- Rising incidence of NTM lung disease is observed, particularly in low tuberculosis prevalence areas.
Purpose of the Study:
- To highlight the clinical significance of NTM in respiratory tract colonization.
- To address challenges in differentiating NTM infections from tuberculosis or bronchiectasis.
- To emphasize the need for individualized treatment strategies for NTM lung disease.
Main Methods:
- Review of current literature on NTM epidemiology and clinical presentation.
- Analysis of diagnostic challenges in distinguishing NTM from other pulmonary conditions.
- Discussion of therapeutic approaches for NTM infections.
Main Results:
- NTM lung disease diagnosis is complex, often mimicking tuberculosis.
- Accurate differentiation is essential for appropriate patient management.
- Common NTM lung pathogens in Slovakia include Mycobacterium avium and Mycobacterium abscessus.
Conclusions:
- NTM lung disease requires careful evaluation, especially in patients with pre-existing lung conditions.
- Treatment necessitates individualized regimens, often combining antituberculotics and antibiotics.
- Ongoing research is needed to improve diagnostic accuracy and therapeutic outcomes for NTM infections.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Methods of Classification and Identification
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

